(1)
ASSESSMENT OF PTEN TUMOR SUPPRESSOR PROTEIN BY IMMUNOHISTOCHEMISTRY IN ENDOMETRIAL HYPERPLASIAS VERSUS CARCINOMAS OVER A FOUR-YEAR PERIOD. A-JMRHS 2026, 4 (2), 1212-1216.